Prevalence of ocular manifestations in systemic sclerosis patients

被引:47
作者
Waszczykowska, Arleta [1 ]
Gos, Roman [2 ]
Waszczykowska, Elzbieta [3 ]
Dziankowska-Bartkowiak, Bozena [3 ]
Jurowski, Piotr [1 ]
机构
[1] Med Univ Lodz, Inst Eye Dis Diagnost, Dept Eye Dis 2, PL-90549 Lodz, Poland
[2] Med Univ Lodz, Inst Ophthalmol & Vis Rehabil, Dept Eye Dis 2, PL-90549 Lodz, Poland
[3] Med Univ Lodz, Inst Immunodermatol, PL-90549 Lodz, Poland
关键词
scleroderma; eye complications; retinal changes; GLAUCOMATOUS ABNORMALITIES; LOCALIZED SCLERODERMA; RETINOPATHY;
D O I
10.5114/aoms.2013.39217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Systemic sclerosis (scleroderma, SSc) is a severe chronic connective tissue disease caused by immune system disorders and changes in the structure and functions of blood vessels, which consequently leads to enhanced tissue fibrosis. The aim of the study was to evaluate changes in the organ of vision in systemic sclerosis patients. Material and methods: Overall the study involved 27 patients with systemic sclerosis. The control group comprised 27 age- and gender-matched healthy individuals. All the study subjects underwent complete ophthalmological examination that in systemic sclerosis patients additionally involved fluorescein angiography. Results: Ophthalmological examination revealed higher incidence of the following abnormalities in the study group, compared to the control: symptoms of dry eye syndrome (19 eyes, p < 0.02), astigmatism(in 30 eyes, p < 0.01), posterior subcapsular cataract (10 eyes, p < 0.05), increased intraocular pressure (> 21 mm Hg were observed in 11 eyes, p < 0.002) and vascular abnormalities within fundus in fluorescein angiography (20 eyes). Conclusions: In patients with systemic sclerosis numerous abnormalities within the vision of organ may be found. Regular ophthalmological examinations are essential among the mentioned group. The examination should be particularly focused on the presence of retinal vascular abnormalities.
引用
收藏
页码:1107 / 1113
页数:7
相关论文
共 32 条
  • [1] Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis
    Airo, Paolo
    Scarsi, Mirko
    Rossi, Mara
    Mondini, Michele
    [J]. RHEUMATOLOGY INTERNATIONAL, 2008, 28 (07) : 703 - 707
  • [2] Albert DM, 2000, PRINCIPLES PRACTICE, V5, P4589
  • [3] Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis
    Allanore, Y
    Parc, C
    Monnet, D
    Brézin, AP
    Kahan, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) : 1276 - 1278
  • [4] BERNDT K, 1977, KLIN MONATSBL AUGENH, V171, P597
  • [5] Boschi A, 1993, Eur J Ophthalmol, V3, P219
  • [6] Chan AYK, 2005, ANN RHEUM DIS, V64, P341
  • [7] Chmiel K, 2011, POSTEP DERM ALERGOL, V28, P506
  • [8] Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis
    Clements, P. J.
    Roth, M. D.
    Elashoff, R.
    Tashkin, D. P.
    Goldin, J.
    Silver, R. M.
    Sterz, M.
    Seibold, J. R.
    Schraufnagel, D.
    Simms, R. W.
    Bolster, M.
    Wise, R. A.
    Steen, V.
    Mayes, M. D.
    Connelly, K.
    Metersky, M.
    Furst, D. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (12) : 1641 - 1647
  • [9] Danczak-Pazdrowska A, 2012, POSTEP DERM ALERGOL, V29, P182
  • [10] Das CP, 2002, NEUROL INDIA, V50, P504